Habermann JK - Search Results

1

Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies.

Gemoll T, Epping F, Heinrich L, Fritzsche B, Roblick UJ, Szymczak S, Hartwig S, Depping R, Bruch HP, Thorns C, Lehr S, Paech A, Habermann JK. Gemoll T, et al. Among authors: habermann jk. Oncotarget. 2015 Jun 30;6(18):16517-26. doi: 10.18632/oncotarget.4140. Oncotarget. 2015. PMID: 26203049 Free PMC article.

2

MALDI mass spectrometry imaging in oncology (Review).

Gemoll T, Roblick UJ, Habermann JK. Gemoll T, et al. Among authors: habermann jk. Mol Med Rep. 2011 Nov-Dec;4(6):1045-51. doi: 10.3892/mmr.2011.566. Epub 2011 Aug 22. Mol Med Rep. 2011. PMID: 21874241 Review.

3

MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer.

Gemoll T, Strohkamp S, Schillo K, Thorns C, Habermann JK. Gemoll T, et al. Among authors: habermann jk. Oncotarget. 2015 Dec 22;6(41):43869-80. doi: 10.18632/oncotarget.6103. Oncotarget. 2015. PMID: 26556858 Free PMC article.

4

EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer.

Gemoll T, Kollbeck SL, Karstens KF, Hò GG, Hartwig S, Strohkamp S, Schillo K, Thorns C, Oberländer M, Kalies K, Lehr S, Habermann JK. Gemoll T, et al. Among authors: habermann jk. Oncotarget. 2017 Jul 4;8(33):54939-54950. doi: 10.18632/oncotarget.18978. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903393 Free PMC article.

5

SELDI-TOF serum proteomics and colorectal cancer: a current overview.

Gemoll T, Roblick UJ, Auer G, Jörnvall H, Habermann JK. Gemoll T, et al. Among authors: habermann jk. Arch Physiol Biochem. 2010 Oct-Dec;116(4-5):188-96. doi: 10.3109/13813455.2010.495130. Epub 2010 Jul 8. Arch Physiol Biochem. 2010. PMID: 20615064 Review.

6

From genome to proteome in tumor profiling: molecular events in colorectal cancer genesis.

Habermann JK, Roblick UJ, Upender M, Ried T, Auer G. Habermann JK, et al. Adv Exp Med Biol. 2006;587:161-77. doi: 10.1007/978-1-4020-5133-3_15. Adv Exp Med Biol. 2006. PMID: 17163165 Review.

7

From the genome to the proteome--biomarkers in colorectal cancer.

Habermann JK, Bader FG, Franke C, Zimmermann K, Gemoll T, Fritzsche B, Ried T, Auer G, Bruch HP, Roblick UJ. Habermann JK, et al. Langenbecks Arch Surg. 2008 Jan;393(1):93-104. doi: 10.1007/s00423-007-0230-1. Epub 2007 Oct 16. Langenbecks Arch Surg. 2008. PMID: 17938952 Review.

8

Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.

Roblick UJ, Bader FG, Hammarstedt L, Habermann JK, Hellman U, Becker S, Sundmacker A, Gemoll T, Zimmermann K, Auer G, Munck-Wikland E. Roblick UJ, et al. Among authors: habermann jk. Acta Oncol. 2008;47(8):1493-501. doi: 10.1080/02841860802314696. Acta Oncol. 2008. PMID: 18759147

9

Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes.

Habermann JK, Bündgen NK, Gemoll T, Hautaniemi S, Lundgren C, Wangsa D, Doering J, Bruch HP, Nordstroem B, Roblick UJ, Jörnvall H, Auer G, Ried T. Habermann JK, et al. Mol Cancer. 2011 Oct 31;10:132. doi: 10.1186/1476-4598-10-132. Mol Cancer. 2011. PMID: 22040021 Free PMC article.

10

Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis.

Gerling M, Nousiainen K, Hautaniemi S, Krüger S, Fritzsche B, Homann N, Bruch HP, Auer G, Roblick UJ, Ried T, Habermann JK. Gerling M, et al. Among authors: habermann jk. Inflamm Bowel Dis. 2013 Mar-Apr;19(4):691-703. doi: 10.1097/MIB.0b013e31827eeaa4. Inflamm Bowel Dis. 2013. PMID: 23455720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters